ARCHIVES

FDA Approves Tamoxifen For “Reduction In Incidence,” Avoids Word “Prevention”

This article is from The Cancer Letter archive.

Vol. 24 No. 42 | November 6, 1998

Download PDF Visit The Full Archive

Related Articles

In Brief: Ed Moorhead, Community Cancer program Leader, Dies At Age 50; Ficca Appointed NHLBI AO

February 6, 1987

If You Were On ODAC: Experts Suggest Questions For May 10 Advisory Meeting.

March 16, 2007

Gallo, Four Others Share Lasker Award

November 19, 1982

On Capitol Hill: Cancer Organizations Push Congress For Payment Of Patient Care Costs In Trials

September 17, 1999

Human Genome Project publishes its final product.

October 22, 2004

Environmental Carcinogenesis Gets 17% Of NCI Budget

February 20, 1976